Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: J Pharm Sci. 2014 Mar 14;103(5):1375–1383. doi: 10.1002/jps.23939

Table 4.

HS/HP disaccharide composition analysis by LC-MS.

Samples HS/HP disaccharides composition (%)
ΔDi-0S ΔDi-NS ΔDi-6S ΔDi-2S ΔDi-NS6S ΔDi-NS2S ΔDi-2S6S ΔDi-TriS
UFH 0.8 ± 0.2 1.9 ± 0.1 2.4 ± 0.5 1.4 ± 0.5 14.1 ± 0.8 5.4 ± 0.2 1.5 ± 0.2 72.6 ± 0.3
LMWH-II 0.6 ± 0.3 1.8 ± 0.3 1.9 ± 0.5 1.6 ± 0.4 10.5 ± 0.7 5.3 ± 0.3 1.6 ± 0.2 76.8 ± 0.1
Enoxaparin 0.6 ± 0.5 1.8 ± 0.5 2.2 ± 0.8 1.1 ± 0.4 15.2 ± 0.9 4.3 ± 0.4 1.7 ± 0.3 73.1 ± 0.2
*

Data shown in bold indicate significant compositional differences between LMWH-II and UFH and Enoxaparin.